Malignant Urinary Tract Neoplasm — Trials

Malignant Urinary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,954 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 507
Recruiting: 271
Ph III recruiting: 36
Growth YoY: +22.2%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (246)

clinicaltrialsPublishedShowing 51–76 of 76 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04219046	Evaluation of Naloxegol in the Prevention of POI After Cystectomy(ANTAGOCYST)	unknown	Phase 2	102	Institut Paoli-CalmettesOTHER	0	Jul 28, 2020	clinicaltrials
NCT02070120	Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer(CALIBER)	unknown	Phase 2	82	Institute of Cancer Research, United KingdomOTHER	1	Mar 19, 2020